Activation of SIRT1 activity, mediated by thyroid hormones, was proved to induce PGC1α activity and increase CPT1A mRNA expression . Thyroid hormone increases the number of lipid-laden autophagosomes and lysosomes in hepatic cells in a THR-dependent manner . As serum TSH concentration changes with the feedback of TH levels, interaction between thyroid hormones and TSH might also relate to the lipolytic action of thyroid hormones. A study in 2015 about cultured rat hepatocytes suggested that the ATGL recruitment to the surface of lipid droplet (LD) reduced lipid storage and the activity of LD-related proteins, which was related to TH level . The effect of thyroid hormones on ATGL expression and activity in hepatocytes is still unknown. Unfortunately, we did not have enough protein for additional studies of other adrenoceptors, G-proteins or phosphodiesterases. The amount of cells available for such detailed studies was far too small. As testosterone caused a similar degree of inhibition, regardless of whether lipolysis was stimulated with adrenaline, adrenaline plus yohimbine, isoprenaline or dcAMP, the major inhibitory effect is probably downstream of cyclic AMP formation. The site-specific effect of testosterone is probably not related to adipocyte differentiation, since the hormone had no effect on pre-adipocyte maturation as measured by GPDH activity, a finding which is consistent with previous results . This happens despite a reduced rate of fatty acid synthesis and decreased expression of numerous genes involved in lipogenesis (Shimano et al., 1999). Conversely, a diet rich in carbohydrates stimulates lipogenesis in both liver and adipose tissue, leading to elevated postprandial plasma triglyceride levels. Polyunsaturated fatty acids decrease lipogenesis by suppressing gene expression in liver, including that of fatty acid synthase, spot14 and stearoyl-CoA desaturase (Jump et al., 1994). Although acute high T does not affect total lipid oxidation, it does increase VLDL-TG secretion, indicating that androgens can affect hepatic lipid metabolism through fast nongenomic pathways. This is further complicated by the fact that T treatment of hypogonadal populations of different age and etiology seems to affect metabolism and body composition differently (52). Whereas T primarily stimulates extrahepatic and not hepatic lipid oxidation in humans (51), limited data are available on other tissues such as heart, kidney, and brain, warranting further research. Impaired lipid oxidation, even before any signs of insulin resistance or changes in REE, may therefore be an early metabolic feature of male hypogonadism, in which noninhibited peripheral LPL activity may lead to increased TG uptake and storage. Although no differences in muscle LPL expression were detected, this hypothesis is supported by the trend toward higher eugonadal VLDL-TG oxidation rates and the significantly lower total lipid oxidation found in all hypogonadal arms regardless of intervention. This could indicate an increased channeling of TG away from storage in fat tissue toward oxidative pathways in muscle. Epinephrine binding leads to adenylyl cyclase activation, an increase in extracellular cAMP levels, and subsequent phosphorylation and activation of AMPK, thereby inhibiting adipogenesis. FATPs and L-FABPs are protein transporters which mediate FFA-entering hepatocytes for substrates of liver TG synthesis. SREBP, ChREBP and FoxO are important transcription factor regulating lipid production. Mouse models with specific knockout of hepatic GHR/JAK2/STAT5 signals exhibited a rise in circulating GH levels and reducing systemic insulin sensitivity, and thereby hyperinsulinemia, hyperglycemia, and WAT lipolysis 182,190,191. There is evidence showing that GH reduces the DNL of adipose tissue , leading to significant fat mass loss. Growth hormone secretion reaches maximum levels during puberty and was accompanied by very high circulating insulin-like growth factor (IGF-I) levels . However, this well-accepted view is not completely consistent with the results of some studies evaluating exogenous steroids effects on plasma–lipid dynamics and concentrations. Although we could not detect an effect of DHEA or T on postabsorptive lipolysis (16), we cannot infer the same for postprandial lipolysis. Hence, replacement of androgens in elderly men and women who have plasma concentrations of DHEA and T below the normal range for young adults may not improve fat distribution or adipose function. For both sexes, a univariate analysis showed no difference in changes in systemic lipolysis during the MMTT or IVGTT in the DHEA group and T group when compared with placebo.